BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
12/12/18 Mallinckrodt (MNK) MNK-812 for Acute Pain Subscribers Only Subscribers Only Subscribers Only
12/12/18 Neurocrine (NBIX) Ingrezza for Tourette's Syndrome Subscribers Only Subscribers Only Subscribers Only
12/11/18 Intra-Cellular Therapies (ITCI) Lumateperone for Schizophrenia Subscribers Only Subscribers Only Subscribers Only
12/11/18 Portola (PTLA) Andexxa for Drug Toxicity Subscribers Only Subscribers Only Subscribers Only
12/10/18 Novan (NOVN) SB206 for Antiviral - Other Treatments Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
12/13/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 12/14/18 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
Now - 12/14/18 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
12/14/18 Subscribers Only Subscribers Only Trial Data - Updated Results
12/14/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top